— Know what they know.
Not Investment Advice
Also trades as: 0IV3.L (LSE) · $vol 0M

GERN NASDAQ

Geron Corporation
1W: -7.3% 1M: -8.0% 3M: -17.9% YTD: -12.9% 1Y: -7.3% 3Y: -35.0% 5Y: -19.0%
$1.15
+0.00 (+0.00%)
Pre-Market: $1.16 (+0.01, +0.87%)
Weekly Expected Move ±5.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $738.8M mcap · 556M float · 1.88% daily turnover · Short 52% of daily vol
Credit Risk of going bust: higher than 60% of companies Debt: 14.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Geron Corporation would be worth roughly what it owes.
Total debt $122.1M against a stock market value of $738.8M.
Distance to default 4.22 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $60.1M (short-term plus half of long-term), stock volatility 62.8%; Altman Z'' -6.31. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$571M -3.9% ▼
5Y CAGR: +16.1%
Total Liabilities
$345M +10.0% ▲
5Y CAGR: +42.0%
Shareholders Equity
$226M -19.4% ▼
5Y CAGR: +1.4%
Cash & Investments
$360M -11.5% ▼
5Y CAGR: +12.9%
Total Debt
$252M +106.7% ▲
5Y CAGR: +53.3%
Net Debt
$172M +303.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$35M$57M$70M$79M$79M
Short-Term Investments$149M$116M$264M$328M$280M
Cash & ST Investments$184M$173M$334M$407M$360M
Net Receivables$2M$3M$2M$39M$39M
Inventory$0$0$0$39M$0
Other Current Assets$364K$4M$6M$7M$121M
Total Current Assets$187M$180M$341M$491M$520M
Property, Plant & Equip.$5M$5M$5M$4M$884K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$29M$0$43M$95M$41M
Other Non-Current Assets$5M$5M$5M$4M$8M
Total Non-Current Assets$39M$10M$53M$103M$50M
Total Assets$226M$191M$394M$594M$571M
— Liabilities —
Accounts Payable$7M$10M$6M$9M$11M
Short-Term Debt$0$21M$47M$0$18M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$8M$12M$14M$43M$81M
Total Current Liabilities$46M$77M$108M$88M$112M
Long-Term Debt$50M$30M$35M$118M$232M
Other Non-Current Liab.$0$0$0$104M$0
Total Non-Current Liabilities$54M$34M$38M$225M$233M
Total Liabilities$100M$111M$146M$313M$345M
— Equity —
Common Stock$324K$390K$545K$606K$640K
Retained Earnings-$1.3B-$1.4B-$1.6B-$1.8B-$1.9B
Accumulated OCI-$173K-$219K$185K$261K$269K
Total Stockholders Equity$126M$80M$248M$280M$226M
Total Liabilities & Equity$226M$191M$394M$594M$571M
— Key Metrics —
Total Debt$55M$56M$86M$122M$252M
Net Debt$20M-$1M$16M$43M$172M
Total Investments$178M$116M$307M$422M$322M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms